一名接受依那西普治疗的类风湿关节炎患者发生致命性肺部偶发分枝杆菌感染。
Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.
作者信息
Maimon Nimrod, Brunton James, Chan Adrienne K, Marras Theodore K
机构信息
Division of Respirology, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada.
出版信息
Thorax. 2007 Aug;62(8):739-40. doi: 10.1136/thx.2005.056952.
Abstract
Mycobacterium xenopi is a water-related mycobacterium with low pathogenicity in humans. Little is known about the association between anti-tumour necrosis factor (TNF)alpha and non-tuberculous mycobacterial infections. The case history is presented of fatal M xenopi infection in a patient receiving anti-TNFalpha treatment.
摘要
偶发分枝杆菌是一种与水相关的分枝杆菌，对人类致病性较低。关于抗肿瘤坏死因子（TNF）α与非结核分枝杆菌感染之间的关联，目前所知甚少。本文报告了一例接受抗TNFα治疗的患者发生致命性偶发分枝杆菌感染的病例。
相似文献
1
Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.一名接受依那西普治疗的类风湿关节炎患者发生致命性肺部偶发分枝杆菌感染。
Thorax. 2007 Aug;62(8):739-40. doi: 10.1136/thx.2005.056952.
2
Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.一名接受依那西普治疗的类风湿关节炎患者发生致命性链球菌中毒性休克综合征。
Rheumatology (Oxford). 2005 Sep;44(9):1200-1. doi: 10.1093/rheumatology/keh680. Epub 2005 May 3.
3
Fatal pulmonary Mycobacterium abscessus infection in a patient using etanercept.一名使用依那西普的患者发生致命性肺脓肿分枝杆菌感染。
Hawaii Med J. 2006 Jan;65(1):12-5.
4
The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.泰国人群中抗肿瘤坏死因子药物的感染谱：一项基于大学医院的回顾性研究。
Int J Rheum Dis. 2009 Jul;12(2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x.
5
6
Mycobacterium mucogenicum: report of a skin infection associated with etanercept.黏液产生分枝杆菌：一例与依那西普相关的皮肤感染报告。
Dermatol Online J. 2008 Jan 15;14(1):5.
7
Pneumococcal meningitis and etanercept--chance or association?肺炎球菌性脑膜炎与依那西普——偶然还是存在关联？
J Infect. 2005 Aug;51(2):E49-51. doi: 10.1016/j.jinf.2004.08.015.
8
Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab.英夫利昔单抗治疗难治性多发性肌炎时发生的致死性海分枝杆菌肺炎
Rheumatology (Oxford). 2005 Sep;44(9):1201-2. doi: 10.1093/rheumatology/keh700. Epub 2005 Jun 7.
9
Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.类风湿关节炎患者接受依那西普治疗后加速性肺结节病的管理。
Rheumatology (Oxford). 2008 Jun;47(6):928-9. doi: 10.1093/rheumatology/ken102. Epub 2008 Apr 2.
10
Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.一名接受英夫利昔单抗治疗的类风湿关节炎患者发生播散性海分枝杆菌感染。
Scand J Infect Dis. 2009;41(4):252-5. doi: 10.1080/00365540902774599.
引用本文的文献
1
Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.具有抗干扰素-γ抗体和机会性细胞内微生物的HIV阴性免疫缺陷中的细胞免疫反应。
PLoS One. 2014 Oct 20;9(10):e110276. doi: 10.1371/journal.pone.0110276. eCollection 2014.
2
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.一名接受肿瘤坏死因子-α抑制剂治疗的患者对播散性非结核分枝杆菌病治疗的矛盾反应：病例报告
BMC Infect Dis. 2014 Feb 28;14:114. doi: 10.1186/1471-2334-14-114.
3
Inventory study of non-tuberculous mycobacteria in the European Union.欧盟中非结核分枝杆菌的库存研究。
BMC Infect Dis. 2014 Feb 6;14:62. doi: 10.1186/1471-2334-14-62.
4
Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report.一名类风湿关节炎患者在使用依那西普治疗期间因季节性流感疫苗接种后发生感染性休克：病例报告
Clin Vaccine Immunol. 2013 May;20(5):761-4. doi: 10.1128/CVI.00081-13. Epub 2013 Mar 6.
5
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.类风湿关节炎患者接受生物制剂治疗后肺部非结核分枝杆菌病的放射学特征和治疗反应：日本的一项回顾性多中心研究。
Mod Rheumatol. 2012 Sep;22(5):727-37. doi: 10.1007/s10165-011-0577-6. Epub 2011 Dec 30.
6
Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.抗肿瘤坏死因子-α 治疗的延续是否对发生肺部分枝杆菌感染的患者是一种安全的选择？：病例报告和文献复习。
Clin Rheumatol. 2012 Feb;31(2):203-10. doi: 10.1007/s10067-011-1902-3. Epub 2011 Dec 15.
7
Nontuberculous mycobacteria and the lung: from suspicion to treatment.非结核分枝杆菌与肺部：从怀疑到治疗。
Lung. 2010 Aug;188(4):269-82. doi: 10.1007/s00408-010-9240-9. Epub 2010 Apr 9.
8
Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.非结核分枝杆菌感染与抗肿瘤坏死因子-α治疗。
Emerg Infect Dis. 2009 Oct;15(10):1556-61. doi: 10.3201/eid1510.090310.
本文引用的文献
1
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.抗肿瘤坏死因子药物与结核病风险：作用机制及临床管理
Lancet Infect Dis. 2003 Mar;3(3):148-55. doi: 10.1016/s1473-3099(03)00545-0.
2
Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases.用于治疗风湿性疾病的肿瘤坏死因子-α拮抗剂。
Curr Opin Rheumatol. 2002 May;14(3):204-11. doi: 10.1097/00002281-200205000-00002.
3
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.与英夫利昔单抗（一种肿瘤坏死因子α中和剂）相关的结核病。
N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110.
4
Mycobacterium xenopi: innocent bystander or emerging pathogen?偶发分枝杆菌：无辜旁观者还是新兴病原体？
Clin Infect Dis. 1997 Feb;24(2):226-32.
Zotero 插件